J. Stein

发表

Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice

J. Stein, A. Aksan, W. Klemm, 2018, Journal of Crohn's & colitis.

Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study

J. Stein, O. Schröder, I. Blumenstein, 2006, European journal of gastroenterology & hepatology.

Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study

S. Schreiber, H. Herfarth, M. Reinshagen, 2005, The American Journal of Gastroenterology.

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

P. Marteau, R. Evstatiev, J. Stein, 2011, Gastroenterology.

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.

J. Gisbert, S. Vavricka, G. Savoye, 2015, Journal of Crohn's & colitis.

Current evaluation and management of anemia in patients with inflammatory bowel disease

J. Stein, A. Dignass, H. Radeke, 2017, Expert review of gastroenterology & hepatology.

Anemia and iron deficiency in gastrointestinal and liver conditions

D. Ong, S. Connor, J. Stein, 2016, World journal of gastroenterology.

World Congress Integrative Medicine & Health 2017: Part one

Jeffrey M. Hausdorff, Oleg L. Sorokin, Gregg M. Gascon, 2017, BMC Complementary and Alternative Medicine.

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

H. Tilg, G. Rogler, S. Travis, 2015, Revista de gastroenterologia de Mexico.

Measuring Vitamin D Status in Chronic Inflammatory Disorders: How does Chronic Inflammation Affect the Reliability of Vitamin D Metabolites in Patients with IBD?

J. Stein, A. Aksan, F. Armbruster, 2020, Journal of clinical medicine.

Predictors of Irritable Bowel-Type Symptoms and Healthcare-Seeking Behavior Among Adults With Celiac Disease

F. Musial, W. Caspary, W. Häuser, 2007, Psychosomatic medicine.

W. Caspary, W. Häuser, A. Stallmach, 2006, European journal of gastroenterology & hepatology.

Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.

V. Armstrong, H. Herfarth, G. Adler, 2005, Clinical chemistry.

Editorial: which iron preparation for patients with IBD? Authors’ reply

J. Stein, A. Aksan, H. Radeke, 2017, Alimentary pharmacology & therapeutics.

Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice

J. Stein, A. Aksan, W. Klemm, 2018, Scandinavian journal of gastroenterology.

Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.

P. Marteau, R. Evstatiev, J. Stein, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Iron Deficiency Generates Secondary Thrombocytosis and Platelet Activation in IBD: the Randomized, Controlled ThromboVIT Trial

T. Waldhör, R. Evstatiev, J. Stein, 2013, Inflammatory bowel diseases.

A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose

G. Rosano, S. Bonassi, J. Stein, 2020, Journal of clinical medicine.

Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease

J. Stein, A. Aksan, H. Radeke, 2017, Alimentary pharmacology & therapeutics.

Letter to the editor: in response to: Richard F Pollock & Patrick Biggar. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia

J. Stein, A. Aksan, A. Dignass, 2021, Expert review of hematology.

An Etiologic Profile of Anemia in 405 Geriatric Patients

J. Stein, M. Bach, J. Martín, 2014, Anemia.

Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease

J. Stein, A. Aksan, C. Nebe, 2021, Diagnostics.

Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review

J. Stein, A. Aksan, F. Zepp, 2022, European Journal of Pediatrics.

Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease

J. Stein, A. Aksan, K. Farrag, 2021, Annals of gastroenterology.

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left‐sided ulcerative colitis

J. Stein, F. Hartmann, 2010, Alimentary pharmacology & therapeutics.

T1238 Controlled, Open, Randomized Multicenter Trial Comparing the Effects of Treatment on Quality of Life, Safety and Efficacy of Budesonide and Mesalazine Enemes in Active Left-Sided Ulcerative Colitis

J. Stein, F. Hartmann, 2010 .

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

V. Armstrong, H. Herfarth, G. Adler, 2007, Clinical chemistry.

The Chemopreventive Agent Resveratrol Stimulates Cyclic AMP–Dependent Chloride Secretion In vitro

B. Keserü, J. Stein, I. Blumenstein, 2005, Clinical Cancer Research.

Refeeding Syndrome: An Important Complication Following Obesity Surgery

J. Stein, S. Chiappetta, 2016, Obesity Facts.

Chronic intestinal failure and short bowel syndrome in Crohn’s disease

J. Stein, A. Aksan, A. Dignass, 2021, World journal of gastroenterology.

Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis

J. Stein, A. Aksan, O. Schröder, 2022, Surgical Endoscopy.

Significant Differences Between Crohn’s Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients

P. Rutgeerts, D. Hommes, M. Neurath, 2010, Digestive Diseases and Sciences.

Management of Inflammatory Bowel Diseases during Pregnancy

J. Stein, A. Dignass, A. Sturm, 2009, Digestive Diseases.

1157 Modified Release Phosphatidylcholine LT-02 in Active Ulcerative Colitis - a Randomized, Placebo-Controlled Multicentre Study

L. Kupčinskas, W. Stremmel, J. Stein, 2012 .

Coeliac Disease – New Pathophysiological Findings and Their Implications for Therapy

D. Schuppan, J. Stein, J. Stein, 2014, Visceral Medicine.

Osteopontin Levels in Human Milk Are Related to Maternal Nutrition and Infant Health and Growth

G. Samur, J. Stein, A. Aksan, 2021, Nutrients.

Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice

J. Stein, A. Aksan, A. Dignass, 2017, Expert opinion on pharmacotherapy.

Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort

J. Stein, A. Dignass, I. Blumenstein, 2019, Journal of clinical medicine.

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

J. Stein, K. Nip, D. Baumgart, 2018, ClinicoEconomics and outcomes research : CEOR.

Plasma concentrations of ascorbic acid in a cross section of the German population

M. Neurath, A. Hagel, J. Stein, 2017, The Journal of international medical research.

Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker

J. Stein, A. Aksan, A. Arnold, 2022, Journal of clinical medicine.

Primary Manifestation of Inflammatory Bowel Disease Following Subcutaneous Autovaccination.

M. Neurath, A. Hagel, J. Stein, 2015, Journal of Crohn's & colitis.

Enteral Nutrition by Endoscopic Means; I. Techniques, Indications, Types of Enteral Feed

J. Stein, N. Hoepffner, O. Schröder, 2004, Zeitschrift fur Gastroenterologie.

Medikamentöse Therapie der Zöliakie – „from bench to bedside“

D. Schuppan, J. Schulzke, J. Stein, 2017, Zeitschrift für Gastroenterologie.

Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS)

J. Langhorst, G. Rogler, F. Autschbach, 2019, Zeitschrift für Gastroenterologie.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.

Laurent Beaugerie, Herbert Tilg, H. Tilg, 2013, Journal of Crohn's & colitis.

Superoxide: A Major Factor for Stress Protein Induction in Reoxygenation Injury in the Intestinal Cell Line Caco-2

W. Caspary, J. Stein, H. Boehles, 1999, Digestion.

Medical Therapy of GERD

J. Stein, K. Farrag, J. Stein, 2020 .

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions

J. Stein, A. Dignass, K. Farrag, 2018, International journal of chronic diseases.

Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.

J. Stein, A. Aksan, T. Iqbal, 2020, Journal of Crohn's & colitis.

The German hospital malnutrition study.

Dorothee Volkert, Peter Bauer, Matthias Pirlich, 2006, Clinical nutrition.

Flipside of the Coin: Iron Deficiency and Colorectal Cancer

J. Stein, A. Aksan, Oliver Schroeder, 2021, Frontiers in Immunology.

Percutaneous Endoscopic Gastrostomy (PEG)

J. Stein, A. Aksan, Y. Shastri, 2020, Encyclopedia of Gastroenterology.

Gastroenteric tube feeding: techniques, problems and solutions.

J. Stein, I. Blumenstein, Y. Shastri, 2014, World journal of gastroenterology.

New introducer PEG gastropexy does not require prophylactic antibiotics: multicenter prospective randomized double-blind placebo-controlled study.

J. Stein, N. Hoepffner, H. Ackermann, 2008, Gastrointestinal endoscopy.

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

J. Mansfield, Fraser Cummings, T. Molnár, 2016, Alimentary pharmacology & therapeutics.

Development and Validation of the Celiac Disease Questionnaire (CDQ), a Disease-specific Health-related Quality of Life Measure for Adult Patients With Celiac Disease

W. Caspary, W. Häuser, A. Stallmach, 2007, Journal of clinical gastroenterology.

Long-Term Effectiveness of Azathioprine in IBD Beyond 4 Years: A European Multicenter Study in 1176 Patients

P. Rutgeerts, D. Hommes, M. Neurath, 2006, Digestive Diseases and Sciences.

[Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014].

J. Langhorst, H. Buhr, P. Kienle, 2014, Zeitschrift fur Gastroenterologie.

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.

A. Berstad, S. Travis, C. Beglinger, 2007, Inflammatory bowel diseases.

Addendum to S3-Guidelines Crohn’s disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic – open questions and answers

J. Langhorst, F. Autschbach, P. Kienle, 2020, Zeitschrift für Gastroenterologie.

A randomized prospective trial of immediate vs. next-day feeding after percutaneous endoscopic gastrostomy in intensive care patients

J. Stein, M. Keymling, A. Schulte-Bockholt, 2002, Intensive Care Medicine.

Inadequate Nutrient Intake in Patients with Celiac Disease: Results from a German Dietary Survey

J. Stein, J. Martín, C. Maresch, 2013, Digestion.

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn’s disease

J. Stein, A. Dignass, J. Thieringer, 2020, United European gastroenterology journal.

Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review

J. Stein, A. Aksan, F. Zepp, 2022, European Journal of Pediatrics.

[Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases].

M. Zeitz, H. Buhr, J. Schölmerich, 2003, Zeitschrift fur Gastroenterologie.

Clinical Significance of C-Reactive Protein Levels in Predicting Responsiveness to Iron Therapy in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia

J. Stein, C. Gasche, T. Iqbal, 2014, Digestive Diseases and Sciences.

Serum Hepcidin Levels Predict Intestinal Iron Absorption in Patients with Inflammatory Bowel Disease.

J. Stein, A. Aksan, T. Iqbal, 2019, Clinical laboratory.

Percutaneous endoscopic gastrostomy (PEG): a practical approach for long term management

J. Stein, A. Aksan, U. Beilenhoff, 2019, British Medical Journal.

A glycerin hydrogel-based wound dressing prevents peristomal infections after percutaneous endoscopic gastrostomy (PEG): a prospective, randomized study.

S. Loitsch, C. Bott, J. Stein, 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure

T. Rösch, J. Aberle, J. Seufert, 2018, BMC Gastroenterology.

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries

F. Mearin, S. Danese, É. Lerebours, 2013, European journal of gastroenterology & hepatology.

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

J. Stein, A. Dignass, K. Chow, 2012, Current medical research and opinion.

Management of iron deficiency anemia in inflammatory bowel disease – a practical approach

J. Stein, A. Dignass, J. Stein, 2013, Annals of gastroenterology.

P380 Safety and efficacy of bolus administered ferric carboxymaltose (500 mg) in the treatment of iron deficiency anaemia in IBD patients

J. Stein, S. Weber-Mangal, A. Dignass, 2013 .

Fast-track rescue weight reduction therapy to achieve rapid technical operability for emergency bariatric surgery in patients with life-threatening inoperable severe obesity - A proof of concept study.

J. Stein, C. Stier, R. Stier, 2022, Clinical nutrition ESPEN.